Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.94 USD | -2.79% | +3.16% | +34.03% |
May. 24 | Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing | MT |
May. 21 | Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.03% | 2.83B | |
+19.33% | 125B | |
+13.95% | 108B | |
-3.53% | 24.57B | |
+4.48% | 22.82B | |
-10.42% | 18.19B | |
-41.48% | 16.54B | |
-12.62% | 16.5B | |
+0.99% | 13.39B | |
+21.79% | 11.1B |
- Stock Market
- Equities
- PTCT Stock
- News PTC Therapeutics, Inc.
- Transcript : PTC Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 08